Myosin Therapeutics Closes Second Seed Round to Advance Clinical Trials for Innovative Cancer and Neuroscience Therapies
Myosin Therapeutics, Inc., a biotechnology company developing novel therapies for cancer and neurological disorders, has ...
Chowhound on MSN11d
The Patty Mistake That Makes Burgers Taste Like Cardboard
If you make burgers at home, there's a common mistake that people make that results in a tough, cardboard-like burger. Here's ...
Scripps Institute spin-out company raises $3 million
A Jupiter company secured millions in a seed funding round backed by Florida-based investors such as DeepWork Capital and the Florida Opportunity Fund.
Nature23y
The myosin swinging cross-bridge model
No biological system has been studied by more diverse approaches than the actin-based molecular motor myosin. Biophysics, biochemistry, physiology, classical genetics and molecular genetics have ...
Edgewise Therapeutics to Present on Sevasemten for the Treatment of Becker Muscular Dystrophy at the 2025 MDA Clinical and Scientific Conference
Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that the company will present data on sevasemten, an investigational orally ...
Cytokinetics to Participate in March Investor Conferences
LeerinkGlobal Biopharma Conference: Robert I. Blum, President and Chief Executive Officer, and Andrew Callos, Executive Vice President and Chief Commercial Officer, will participate in a fireside chat ...